Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation for prevention of ventilator-associated pneumonia in mechanically ventilated neonates
ChiCTR-IPR-17013279Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ambroxol in ventilator-associated pneumonia (VAP) (3 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: Incidence of ventilator-associated pneumonia, Duration of mechanical ventilation and 2 more. Started Oct 2017; status: recruiting.
02
Drugs
ambroxol
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on ChiCTR-IPR-17013279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013279.